Evidence map›Paper›PMID 21816865›Full record

ArticleMolecular biology and evolution2012

Crohn's disease and genetic hitchhiking at IBD5.

Chad D Huff, David J Witherspoon, Yuhua Zhang, Chandler Gatenbee, Lee A Denson, Subra Kugathasan, Hakon Hakonarson, April Whiting, Chadwick T Davis, Wilfred Wu and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology and evolution, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. FADS1 and the Timing of Human Adaptation to Agriculture.Molecular biology and evolution · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Chad D HuffDepartment of Human Genetics, Eccles Institute of Human Genetics, University of Utah, UT, USA. chadhuff@yahoo.com
David J Witherspoon
Yuhua Zhang
Chandler Gatenbee
Lee A Denson
Subra Kugathasan
Hakon Hakonarson
April Whiting
Chadwick T Davis
Wilfred Wu
Jinchuan Xing
W Scott Watkins
Michael J Bamshad
Jonathan P Bradfield
Kazima Bulayeva
Tatum S Simonson
Lynn B Jorde
Stephen L Guthery
University of Utah · USChildren's Hospital of Philadelphia · USEmory University · USUniversity of Cincinnati · USUniversity of Pennsylvania · USUniversity of Washington · USVavilov Institute of General Genetics · RU

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Theresa Alenghat · 2007 to 2026
$24.4M
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1: BPCAUL1RR025764 · NCRR · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2008 to 2011
$19.4M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
POPULATION GENETICS OF MOBILE ELEMENTSR01GM059290 · NIGMS · UNIVERSITY OF UTAH · PI BATZER, MARK A, FESCHOTTE, CEDRIC · 1999 to 2018
$8.5M
TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
Multidisciplinary Pulmonary and Critical Care Training ProgramT32HL105321 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Ramsey Hachem, Robert Paine · 2010 to 2026
$4.5M
Biomarkers for Inflammatory Bowel Disease Behavior and Treatment ResponseR01DK078683 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI DENSON, LEE ARMISTEAD · 2009 to 2012
$2.0M
Cytokine Regulation of Growth Hormone SignalingR01DK068164 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI DENSON, LEE ARMISTEAD · 2006 to 2010
$1.4M
Genetic basis of IBD susceptibility &steroid responseK23DK069513 · NIDDK · UNIVERSITY OF UTAH · PI GUTHERY, STEPHEN L · 2005 to 2008
$540k
High-throughput Mobile Element Genotyping Using Next-generation SequencingK99HG005846 · NHGRI · UNIVERSITY OF UTAH · PI XING, JINCHUAN · 2010 to 2011
$179k
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR011234 · NCRR · UNIVERSITY OF UTAH · PI MATSEN, JOHN M · 1995 to 1995
–
NCATS NIH HHS UL1 TR000077NCI NIH HHS CO6-RR11234NCRR NIH HHS C06 RR011234NCRR NIH HHS UL1 RR025764NCRR NIH HHS UL1-RR025764NHGRI NIH HHS K99 HG005846NHGRI NIH HHS K99HG005846NHLBI NIH HHS 1T32HL105321-01NHLBI NIH HHS T32 HL105321NIDDK NIH HHS 1P30DK078392-01NIDDK NIH HHS DK069513NIDDK NIH HHS K23 DK069513NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK068164NIDDK NIH HHS R01 DK078683NIGMS NIH HHS GM59290NIGMS NIH HHS R01 GM059290NIGMS NIH HHS T32 GM007464
6 · The paper itself

Abstract

Inflammatory bowel disease 5 (IBD5) is a 250 kb haplotype on chromosome 5 that is associated with an increased risk of Crohn's disease in Europeans. The OCTN1 gene is centrally located on IBD5 and encodes a transporter of the antioxidant ergothioneine (ET). The 503F variant of OCTN1 is strongly associated with IBD5 and is a gain-of-function mutation that increases absorption of ET. Although 503F has been implicated as the variant potentially responsible for Crohn's disease susceptibility at IBD5, there is little evidence beyond statistical association to support its role in disease causation. We hypothesize that 503F is a recent adaptation in Europeans that swept to relatively high frequency and that disease association at IBD5 results not from 503F itself, but from one or more nearby hitchhiking variants, in the genes IRF1 or IL5. To test for evidence of recent positive selection on the 503F allele, we employed the iHS statistic, which was significant in the European CEU HapMap population (P=0.0007) and European Human Genome Diversity Panel populations (P≤0.01). To evaluate the hypothesis of disease-variant hitchhiking, we performed haplotype association tests on high-density microarray data in a sample of 1,868 Crohn's disease cases and 5,550 controls. We found that 503F haplotypes with recombination breakpoints between OCTN1 and IRF1 or IL5 were not associated with disease (odds ratio [OR]: 1.05, P=0.21). In contrast, we observed strong disease association for 503F haplotypes with no recombination between these three genes (OR: 1.24, P=2.6×10(-8)), as expected if the sweeping haplotype harbored one or more disease-causing mutations in IRF1 or IL5. To further evaluate these disease-gene candidates, we obtained expression data from lower gastrointestinal biopsies of healthy individuals and Crohn's disease patients. We observed a 72% increase in gene expression of IRF1 among Crohn's disease patients (P=0.0006) and no significant difference in expression of OCTN1. Collectively, these data indicate that the 503F variant has increased in frequency due to recent positive selection and that disease-causing variants in linkage disequilibrium with 503F have hitchhiked to relatively high frequency, thus forming the IBD5 risk haplotype. Finally, our association results and expression data support IRF1 as a strong candidate for Crohn's disease causation.

Indexed as

Case-Control StudiesColonComputer SimulationCrohn DiseaseGene FrequencyHaplotypesHumansInterferon Regulatory Factor-1Linkage DisequilibriumOligonucleotide Array Sequence AnalysisOrganic Cation Transport ProteinsPolymorphism, Single NucleotideRNA, MessengerSelection, GeneticSymportersWhite PeopleInterferon Regulatory Factor-1IRF1 protein, humanOrganic Cation Transport ProteinsRNA, MessengerSLC22A4 protein, humanSymporters

Identifiers

PMID21816865
PMCPMC3245542
OpenAlexW2136780715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.